UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ORA, HAIR, GLCNF, GLNCY and MD

NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Ormat Technologies, Inc. (NYSE:ORA)
Lead Plaintiff Deadline: August 8, 2018
Class Period: August 8, 2017 and May 15, 2018

Allegations: Ormat Technologies made materially false and/or misleading statements or failed to disclose that: there were errors in the income tax provision primarily relating to Ormat’s valuation allowance based on its ability to utilize foreign tax credits in the U.S. prior to their expiration; Ormat netted certain deferred income tax assets and deferred income tax liabilities across different tax jurisdictions that are not permitted to be netted pursuant to United States generally accepted accounting principles; Ormat’s internal controls over financial reporting were ineffective; Ormat would need to restate its second, third and fourth quarter 2017 financial statements and its full-year 2017 financial statements; and as a result, defendants’ statements about Ormat’s business, operations and prospects were materially false and misleading and/or lacked a reasonable bases at all relevant times.

Get additional information about ORA: http://www.kleinstocklaw.com/pslra-c/ormat-technologies-inc-2?wire=3.

Restoration Robotics, Inc. (NASDAQ:HAIR)
Lead Plaintiff Deadline: August 21, 2018
Class Period: purchased shares pursuant and/or traceable to the Company’s Initial Public Offering between October 12, 2017 and October 16, 2017

Allegations: The complaint alleges that Restoration Robotics negligently issued untrue statements of material facts in, and omitted to state material facts required to be stated from, the Offering Materials issued in connection with the Initial Public Offering. The complaint further alleges that as a result of the materially misleading Offering Materials, the Company’s stock price was artificially inflated at the time of the IPO.

Get additional information: http://www.kleinstocklaw.com/pslra-c/restoration-robotics-inc-hair?wire=3.

Glencore plc (OTCMKTS:GLCNF) (OTCMKTS:GLNCY)
Lead Plaintiff Deadline: September 7, 2018
Class Period: September 30, 2016 and July 2, 2018

Allegations: Glencore’s conduct would subject it to heightened scrutiny by U.S. and foreign government bodies resulting in investigations into the company’s compliance with money laundering and bribery laws, as well as the Foreign Corrupt Practices Act; and as a result, defendants’ statements about Glencore’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

On May 18, 2018, Bloomberg reported that the U.K.'s Serious Fraud Office was preparing to open a formal bribery investigation into Glencore. Then on July 3, 2018, Glencore disclosed that the U.S. Department of Justice issued its subsidiary a subpoena to produce documents and other records in connection with its compliance with U.S. money laundering statutes and the Foreign Corrupt Practices Act.

Get additional information: http://www.kleinstocklaw.com/pslra-c/glencore-plc?wire=3.

MEDNAX, Inc. (NYSE:MD)
Lead Plaintiff Deadline: September 10, 2018
Class Period: February 4, 2016 and July 27, 2017

Allegations: the Company's business model was not sustainable; and Mednax's growth was in fact based upon suppressing physician compensation and enforcing non-compete agreements to deter physician defections.

On April 20, 2017, Mednax announced negative financial results for the first quarter of 2017. Then on July 28, 2017, during an earnings call, Mednax announced that the Company failed to complete any acquisitions of anesthesiologist practices during the second quarter and disclosed that any future acquisitions were unlikely. Following this news, shares of Mednax fell from a close of $56.49 on July 27, 2017, to a close of $47.73 per share the following day.

Get additional information about MD: http://www.kleinstocklaw.com/pslra-c/mednax-inc?wire=3.

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
                                                            
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com 
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com